Pharmabiz

Lilly to buy Centessa Pharmaceuticals for $6.3 billion to advance treatments for sleep-wake disorders

Lilly to buy Centessa Pharmaceuticals for $6.3 billion to advance treatments for sleep-wake disorders: Indianapolis Wednesday, April 1, 2026, 09:00 Hrs [IST] Eli Lilly and Company ...
Pharmabiz

Ultra-modern mega bulk drugs park in Raigad to transform pharma landscape in Konkan region of Maharashtra

Ultra-modern mega bulk drugs park in Raigad to transform pharma landscape in Konkan region of Maharashtra: Shardul Nautiyal, Mumbai Wednesday, April 1, 2026, 08:00 Hrs [IST] A mas ...
Opinion
PharmabizOpinion

Permitting large-scale clinical study integrating Ayurveda with modern TB treatment a landmark step: expert

Permitting large-scale clinical study integrating Ayurveda with modern TB treatment a landmark step: expert: Nandita Vijayasimha, Bengaluru Wednesday, April 1, 2026, 08:00 Hrs [IS ...
Pharmabiz

No allocation for SSDRS in 2026-27; Panel recommends Rs. 490 crore for new version

Panel recommends Rs. 490 crore for new version: Gireesh Babu, New Delhi Wednesday, April 1, 2026, 08:00 Hrs [IST] Raising serious concerns over ...
Pharmabiz

TN drugs control dept operates without a regular director; industry says work remains smooth

TN drugs control dept operates without a regular director; industry says work remains smooth: Peethaambaran Kunnathoor, Chennai Wednesday, April 1, 2026, 08:00 Hrs [IST] The Tamil ...
Pharmabiz

NPPA exempts Intas Pharma's patented antipsychotic formulation from DPCO for five years

NPPA exempts Intas Pharma's patented antipsychotic formulation from DPCO for five years: Gireesh Babu, New Delhi Wednesday, April 1, 2026, 08:00 Hrs [IST] The National Pharmaceuti ...
Pharmabiz

Karnataka yet to notify admissions for D Pharm even as state govt announced opening of all colleges on Nov 17

Karnataka yet to notify admissions for D Pharm even as state govt announced opening of all colleges on Nov 17: Nandita Vijay, Bengaluru Saturday, October 31, 2020, 08:00 Hrs [IST] ...
Pharmabiz

Biocytogen grants Taisho Pharmaceutical a license to its RenNano fully human heavy chain-only antibody discovery platform

Biocytogen grants Taisho Pharmaceutical a license to its RenNano fully human heavy chain-only antibody discovery platform: Beijing Tuesday, March 31, 2026, 18:00 Hrs [IST] Biocyto ...
Pharmabiz

Asia Pharma Expo 2026 & Asia Lab Expo 2026 inaugurated in Dhaka

The 17th Asia Pharma Expo 2026 & Asia Lab Expo 2026 was formally inaugurated on March 29, 2026, at 10:00 am at the Bangladesh-China Friendship Exhibition Centre (BCFEC), Purbachal, Dhaka. Organized by ...
Pharmabiz

Acurx Pharma’s DNA Polymerase IIIC inhibitors receives Korean patent

Acurx Pharma’s DNA Polymerase IIIC inhibitors receives Korean patent: Staten Island, New York Tuesday, March 31, 2026, 17:00 Hrs [IST] Acurx Pharmaceuticals, Inc., a late-stage ...
Pharmabiz

Eli Lilly, Daiichi Sankyo ink commercialization agreement in Japan for anti-CGRP antibody, galcanezumab to treat migraine

Eli Lilly, Daiichi Sankyo ink commercialization agreement in Japan for anti-CGRP antibody, galcanezumab to treat migraine: Tokyo Saturday, October 31, 2020, 09:00 Hrs [IST] Eli Li ...
Pharmabiz

Apollo Hospitals leads national training initiative to tackle birth asphyxia in partnership with NNF and IAP

Apollo Hospitals leads national training initiative to tackle birth asphyxia in partnership with NNF and IAP: Our Bureau, Bengaluru Tuesday, March 31, 2026, 16:40 Hrs [IST] Apollo ...